Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Clin Neuropsychol ; 35(1): 81-98, 2021 01.
Article in English | MEDLINE | ID: mdl-32996823

ABSTRACT

Objective: The Inter Organizational Practice Committee (IOPC) convened a workgroup to develop guidance on models to provide neuropsychological (NP) care during the COVID-19 pandemic while minimizing risks of novel coronavirus transmission as lockdown orders are lifted and ambulatory clinical services resume.Method: A collaborative panel of experts from major professional organizations developed provisional guidance for models of neuropsychological practice during the pandemic. The stakeholders included the American Academy of Clinical Neuropsychology/American Board of Clinical Neuropsychology, the National Academy of Neuropsychology, Society of Clinical neuropsychology (Division 40) of the American Psychological Association, the American Board of Professional Neuropsychology, and the American Psychological Association Services, Inc.Results: This guidance reviews the risks and benefits of conducting NP exams in several ways, including standard in-person, mitigated in-person, in-clinic teleneuropsychology (TeleNP), and in-home TeleNP. Strategies are provided for selecting the most appropriate model for a given patient, taking into account four levels of patient risk stratification, level of community risk and the concept of stepped models of care. Links are provided to governmental agency and professional organization resources as well as an outline and discussion of essential infection mitigation processes based on commonalities across recommendations from diverse federal, state, local, and professional organization recommendations.Conclusion: This document provides recommendations and guidance with analysis of the risks relative to the benefits of various models of neuropsychological care during the COVID-19 pandemic. These recommendations may be revised as circumstances evolve, with updates posted continuously on the IOPC website (https://iopc.online/).


Subject(s)
COVID-19 , Neuropsychology/standards , Practice Guidelines as Topic/standards , Societies, Scientific/standards , Telemedicine/standards , Humans
2.
Arch Clin Neuropsychol ; 36(1): 17-28, 2021 Jan 15.
Article in English | MEDLINE | ID: mdl-32997103

ABSTRACT

OBJECTIVE: The Inter Organizational Practice Committee (IOPC) convened a workgroup to develop guidance on models to provide neuropsychological (NP) care during the COVID-19 pandemic while minimizing risks of novel coronavirus transmission as lockdown orders are lifted and ambulatory clinical services resume. METHOD: A collaborative panel of experts from major professional organizations developed provisional guidance for models of neuropsychological practice during the pandemic. The stakeholders included the American Academy of Clinical Neuropsychology/American Board of Clinical Neuropsychology, the National Academy of Neuropsychology, Society of Clinical neuropsychology (Division 40) of the American Psychological Association, the American Board of Professional Neuropsychology, and the American Psychological Association Services, Inc. RESULTS: This guidance reviews the risks and benefits of conducting NP exams in several ways, including standard in-person, mitigated in-person, in-clinic teleneuropsychology (TeleNP), and in-home TeleNP. Strategies are provided for selecting the most appropriate model for a given patient, taking into account four levels of patient risk stratification, level of community risk, and the concept of stepped models of care. Links are provided to governmental agency and professional organization resources as well as an outline and discussion of essential infection mitigation processes based on commonalities across recommendations from diverse federal, state, local, and professional organization recommendations. CONCLUSION: This document provides recommendations and guidance with analysis of the risks relative to the benefits of various models of NP care during the COVID-19 pandemic. These recommendations may be revised as circumstances evolve, with updates posted continuously on the IOPC website (https://iopc.online/).


Subject(s)
COVID-19 , Pandemics , Communicable Disease Control , Humans , Neuropsychological Tests , SARS-CoV-2 , United States/epidemiology
3.
Clin Neuropsychol ; 35(2): 224-226, 2021 02.
Article in English | MEDLINE | ID: mdl-33200630

ABSTRACT

The preservation of the field of neuropsychology as an evidenced-based discipline requires immediate, disruptive, organization-level actions to place assessment methods and research paradigms that reflect the racial, cultural, and linguistic diversity of our society at the heart of our education, training and practice models. In this comment on the Cory article on white privilege, three such concrete organizational level actions are articualted, including adoption of Relevance 2050 learning objectives, a revision of the Houston Conference Guidelines to integrate multiracial/multilingual/multiculturalism within every training experience and competency area, and a pledge from every major national neuropsychology organization to dedicate a percentage of our yearly budgets to directly fund multicultural/multiracial/multilingual norms and cultural competence development.


Subject(s)
Cultural Diversity , Neuropsychology , Cultural Competency , Humans , Neuropsychological Tests , White People
4.
Arch Clin Neuropsychol ; 35(6): 647-659, 2020 Aug 28.
Article in English | MEDLINE | ID: mdl-32666093

ABSTRACT

OBJECTIVE: The Inter Organizational Practice Committee convened a workgroup to provide rapid guidance about teleneuropsychology (TeleNP) in response to the COVID-19 pandemic. METHOD: A collaborative panel of experts from major professional organizations developed provisional guidance for neuropsychological practice during the pandemic. The stakeholders included the American Academy of Clinical Neuropsychology/American Board of Clinical Neuropsychology, the National Academy of Neuropsychology, Division 40 of the American Psychological Association, the American Board of Professional Neuropsychology, and the American Psychological Association Services, Inc. The group reviewed literature; collated federal, regional, and state regulations and information from insurers; and surveyed practitioners to identify best practices. RESULTS: Literature indicates that TeleNP may offer reliable and valid assessments, but clinicians need to consider limitations, develop new informed consent procedures, report modifications of standard procedures, and state limitations to diagnostic conclusions and recommendations. Specific limitations affect TeleNP assessments of older adults, younger children, individuals with limited access to technology, and individuals with other individual, cultural, and/or linguistic differences. TeleNP may be contraindicated or infeasible given specific patient characteristics, circumstances, and referral questions. Considerations for billing TeleNP services are offered with reservations that clinicians must verify procedures independently. Guidance about technical issues and "tips" for TeleNP procedures are provided. CONCLUSION: This document provides provisional guidance with links to resources and established guidelines for telepsychology. Specific recommendations extend these practices to TeleNP. These recommendations may be revised as circumstances evolve, with updates posted continuously at IOPC.online.


Subject(s)
Neuropsychology/methods , Telemedicine/methods , Videoconferencing , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Humans , Informed Consent , Insurance, Health , Licensure , Medicaid , Medicare , Neuropsychological Tests , Pandemics , Pneumonia, Viral/epidemiology , Reimbursement Mechanisms , SARS-CoV-2 , Societies, Scientific , Surveys and Questionnaires , United States/epidemiology
5.
Clin Neuropsychol ; 34(7-8): 1314-1334, 2020.
Article in English | MEDLINE | ID: mdl-32673163

ABSTRACT

Objective: The Inter Organizational Practice Committee (IOPC) convened a workgroup to provide rapid guidance about teleneuropsychology (TeleNP) in response to the COVID-19 pandemic.Method: A collaborative panel of experts from major professional organizations developed provisional guidance for neuropsychological practice during the pandemic. The stakeholders included the American Academy of Clinical Neuropsychology/American Board of Clinical Neuropsychology, the National Academy of Neuropsychology, Division 40 of the American Psychological Association, the American Board of Professional Neuropsychology, and the American Psychological Association Services, Inc. The group reviewed literature, collated federal, regional and state regulations and information from insurers, and surveyed practitioners to identify best practices.Results: Literature indicates that TeleNP may offer reliable and valid assessments, but clinicians need to consider limitations, develop new informed consent procedures, report modifications of standard procedures, and state limitations to diagnostic conclusions and recommendations. Specific limitations affect TeleNP assessments of older adults, younger children, individuals with limited access to technology, and individuals with other individual, cultural, and/or linguistic differences. TeleNP may be contraindicated or infeasible given specific patient characteristics, circumstances, and referral questions. Considerations for billing TeleNP services are offered with reservations that clinicians must verify procedures independently. Guidance about technical issues and "tips" for TeleNP procedures are provided.Conclusion: This document provides provisional guidance with links to resources and established guidelines for telepsychology. Specific recommendations extend these practices to TeleNP. These recommendations may be revised as circumstances evolve, with updates posted continuously at OPC.online.


Subject(s)
Betacoronavirus , Coronavirus Infections/therapy , Neuropsychology/standards , Pandemics , Pneumonia, Viral/therapy , Practice Guidelines as Topic/standards , Telemedicine/standards , Academies and Institutes/standards , Advisory Committees/standards , COVID-19 , Coronavirus Infections/epidemiology , Coronavirus Infections/psychology , Humans , Neuropsychological Tests , Neuropsychology/methods , Pneumonia, Viral/epidemiology , Pneumonia, Viral/psychology , SARS-CoV-2 , Surveys and Questionnaires , Telemedicine/methods , United States/epidemiology
6.
Clin Neuropsychol ; 32(3): 326-344, 2018 04.
Article in English | MEDLINE | ID: mdl-28920510

ABSTRACT

OBJECTIVE: Though some neuropsychological groups have proposed criteria and suggestions for clinical report writing there has never been professional consensus or accepted published guidelines on how to write reports. Given the paucity of guidelines and the evolving practice climate, we sought to survey neuropsychologists and referral source stakeholders to understand current report writing practices. METHOD: The data were collected in two SurveyMonkey surveys via professional list servs, email, and LinkedIn clinical interest groups. RESULTS: Results of the survey indicate many neuropsychologists spend multiple hours writing reports that they believe will not be read completely by stakeholders. A striking 73% of referral sources reported slow turnaround time of neuropsychological reports negatively affected their patient care. Referral sources reported they value the diagnosis/impression and recommendations sections the most; in contrast, they did not find the history, behavioral observations, emotional functioning, or descriptions of cognitive domains sections as useful. CONCLUSIONS: The survey findings highlight the disjuncture between what neuropsychologists typically do in their practice of report writing versus what they believe is useful for patients and referral sources. The survey also highlights differences between writing practices of neuropsychologists and what referral sources identify as the most valuable aspects of reports to assist them in caring for their patients.


Subject(s)
Neuropsychology/standards , Referral and Consultation/standards , Research Report/standards , Stakeholder Participation , Surveys and Questionnaires/standards , Writing/standards , Female , Humans , Male , Neuropsychological Tests/standards , Neuropsychology/trends , Referral and Consultation/trends , Research Report/trends
7.
Clin Neuropsychol ; 32(1): 1-9, 2018 01.
Article in English | MEDLINE | ID: mdl-29271311
8.
Clin Neuropsychol ; 28(2): 167-80, 2014.
Article in English | MEDLINE | ID: mdl-24528167

ABSTRACT

In an era of rapid changes in the healthcare marketplace the specialty of clinical neuropsychology faces a substantial increase in advocacy challenges. These include maintaining both access to services and a favorable practice climate as new healthcare structures and payment models evolve. The issue of regional variability complicates an effective response to these challenges from national professional organizations. One response to the challenge of regional variability is to strengthen our national organizations' capacity to engage in coordinated and effective advocacy, and to partner with state and regional neuro/psychological associations. The Inter-Organizational Practice Committee (IOPC) was formed in 2012 to meet this need. The IOPC has developed a model of 360 Degree Advocacy that coordinates local, regional, and national resources for high-impact, efficient advocacy. This paper describes the 360 Degree Advocacy model, and walks readers through an example of the model in action, successfully responding to a threat to patient access and practice climate with a regional Medicare carrier.


Subject(s)
Delivery of Health Care , Health Services Needs and Demand , Patient Advocacy , Delivery of Health Care/organization & administration , Delivery of Health Care/standards , Delivery of Health Care/trends , Humans , Medicare , Patient Advocacy/standards , Patient Advocacy/trends , United States
9.
Cogn Behav Neurol ; 24(3): 107-14, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21945982

ABSTRACT

For both children and adults with neurological, neurodevelopmental, medical, or psychiatric disorders, neuropsychological assessment can be a valuable tool in determining diagnosis, prognosis, and functional abilities as well as informing clinical management. This review summarizes the contributions of neuropsychological assessment to clinical care across diagnostic categories, with the goal of helping clinicians determine its utility for individual patients.


Subject(s)
Developmental Disabilities/diagnosis , Mental Disorders/diagnosis , Nervous System Diseases/diagnosis , Neuropsychological Tests , Humans
10.
Clin Neuropsychol ; 24(6): 1088-1090, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-28950797
SELECTION OF CITATIONS
SEARCH DETAIL
...